Resolution: standard / high
Figure 4.
Mean treatment difference for percentage change in T2 burden of disease (BOD) between interferon (IFN) beta-1a, 44 mcg subcutaneously (sc) three times weekly (tiw), neutralizing antibody negative (NAb-), or IFN beta-1a, 44 mcg sc tiw, NAb+, versus IFN beta-1a, 30 mcg intramuscularly (im) once weekly (qw).
Traboulsee et al. BMC Neurology 2008 8:11 doi:10.1186/1471-2377-8-11
Download authors' original image